Position in ABVX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$67,225,805
-$3,129,356 QoQ
Shares Held
504,471
-20.2% QoQ
Ownership
0.578%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#31
of 301 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ensign Peak Advisors, Inc holds $1,111,483,806 across 123 Biotechnology names. ABVX ranks #3 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
210,483 | $104,553,220 | |
| 2 | INSM |
INSMED Inc
|
702,951 | $74,948,635 | |
| 3 | ABVX |
Abivax S.A.
This page
|
504,471 | $67,225,805 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
760,977 | $56,677,566 | |
| 5 | ARGX |
Argenx SE
|
52,027 | $48,269,089 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
508,056 | $41,442,127 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
591,815 | $33,621,010 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
579,052 | $31,847,860 |
All Filings in ABVX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $67,225,805 | 504,471 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $70,355,161 | 631,838 | Shares | Sole | 2026-08-18 | |
| 2025-12-31 | $69,901,684 | 518,347 | Shares | Sole | 2026-08-18 | |
| 2025-09-30 | $38,687,571 | 455,684 | Shares | Sole | 2026-08-18 | |
| 2025-06-30 | $3,485,982 | 455,684 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,848,025 | 455,684 | Shares | Sole | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||